Amgen Inc.

NASDAQ:AMGN

Drug Manufacturers - General

Healthcare
$443.89 -2.03%

-$6.93 today

Market cap
$240.11B
Beta
0.42
P/E (TTM)
23.2
EPS (TTM)
$14.44
Dividend yield
2.93%
52W Low $267.83High $391.29

Volume 2.58M

Average 2.76M

AMGN Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Amgen Inc.NASDAQ: AMGN

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue declines year over year

Q2 FY2026 cost of revenue of $2.81B fell 6.6% year over year, ahead of the -15.9% change in trailing-twelve-month cost of revenue. Sequentially, it rose 2.4% from the prior quarter. Over 3 fiscal years it compounded at +18.8% a year.

Context

  • Cost of revenue amounted to 29.2% of revenue in FY2025, down 9.3 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -6.6% holds above the trailing-twelve-month pace of -15.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.81B+2.4% QoQ
Last fiscal yearDec 2025
$10.73B-16.6% YoY
LTMJun 2026
$10.43B-15.9% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.6%——
1 year-16.6%——
3-year CAGR+18.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
10.73B USD
Year-over-year change
-16.6%
4-year CAGR
+13.5%

Cost of Revenue vs competitors

How AMGN compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -15.9% is the lowest of 10, against a peer median of +4.5%.
  • Cost of revenue amounts to 27.3% of revenue for AMGN, versus a peer median of 25.6%.
AMGN Competitors
Cost of Revenue for AMGN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
JNJJohnson & JohnsonLTM Sep 2026$30.98B USD+5.3%+7.1%31.2%
PFEPfizer Inc.LTM Jun 2026$17.08B USD-4.0%-22.4%26.8%
MRKMerck & Co., Inc.LTM Jun 2026$16.35B USD+4.5%+1.5%24.6%
ABBVAbbVie Inc.LTM Sep 2026$15.68B USD-13.1%+1.5%23.7%
BMYBristol-Myers Squibb CompanyLTM Jun 2026$14.68B USD+3.6%+11.2%29.8%
NVSNovartis AGLTM Jun 2026$14.22B USD+8.5%+5.7%25.6%
LLYEli Lilly and CompanyLTM Jun 2026$13.23B USD+43.0%+18.6%16.6%
AZNAstraZeneca PLCLTM Sep 2026$12.38B USD+20.9%-5.0%19.9%
AMGNAmgen Inc.LTM Jun 2026$10.43B USD-15.9%+18.8%27.3%
GSKGSK plcLTM Jun 2026£9.06B GBP-0.0%-1.9%27.3%
Peer median (excluding AMGN) —+4.5%+1.5%25.6%

Competitors are the stored peer set for AMGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.98B26.32B28.19B33.42B36.74B
Cost of Revenue6.45B6.41B8.42B12.86B10.73B
Gross Profit19.53B19.92B19.78B20.57B26.01B
Gross Margin75.2%75.7%70.1%61.5%70.8%
Research & Development6.32B4.43B4.78B5.96B6.97B
Selling, General & Admin5.37B5.41B6.18B7.1B7.05B
Operating Expenses11.89B10.35B11.84B13.31B15.34B
Depreciation & Amortization3.4B3.42B4.07B5.59B5.17B
EBITDA11.3B12.17B14.8B13.36B16.9B
EBITDA Margin43.5%46.2%52.5%40.0%46.0%
Operating Income7.64B9.57B7.9B7.26B10.68B
Operating Margin29.4%36.3%28.0%21.7%29.1%
Interest Income00000
Interest Expense1.2B1.41B2.88B3.16B2.76B
Other Income / Expenses(938M)(2.22B)(42M)(2.65B)(1.7B)
Income Before Tax6.7B7.35B7.86B4.61B8.98B
Pre-Tax Margin25.8%27.9%27.9%13.8%24.4%
Income Tax Expense808M794M1.14B519M1.27B
Net Income5.89B6.55B6.72B4.09B7.71B
Net Margin22.7%24.9%23.8%12.2%21.0%
EPS (Basic)10.3412.1812.567.6214.33
EPS (Diluted)10.2812.1112.497.5614.23
Weighted Avg Shares570M538M535M541M538M
Weighted Avg Shares (Diluted)573M541M538M541M542M

Amgen Inc.

NASDAQ:AMGN

Intrinsic Alpha fair value

Locked

Current Price

$443.89

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.